ウロキナーゼの世界市場:メーカー別、地域別、種類別、用途別、市場予測(~2022)

◆英語タイトル:Global Urokinase Market by Manufacturers, Countries, Type and Application, Forecast to 2022
◆商品コード:GIR8012227
◆発行会社(調査会社):GlobalInfoResearch
◆発行日:2017年12月11日
◆ページ数:124
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:医療・バイオ
◆販売価格オプション(消費税別)
Single UserUSD3,480 ⇒換算¥382,800見積依頼/購入/質問フォーム
Corporate UserUSD4,680 ⇒換算¥514,800見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日~2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
本調査レポートでは、ウロキナーゼの世界市場について調査・分析し、ウロキナーゼの世界市場概観、メーカー動向、メーカー別ウロキナーゼシェア、市場規模推移、市場規模予測、ウロキナーゼ種類別分析(ウロキナーゼ粉、ウロキナーゼ溶液)、ウロキナーゼ用途別分析(病院、診療所、その他)、主要地域分析(北米、欧州、アジア)、主要国分析データなどを含め、以下の構成でお届け致します。
・ウロキナーゼの市場概観
・ウロキナーゼのメーカー概要(事業概要、製品種類、価格、売上、市場シェア等)
・ウロキナーゼのメーカー別販売動向、市場シェア、市場集中度、競争動向
・ウロキナーゼの世界市場規模
・ウロキナーゼの北米市場分析(アメリカ、カナダ、メキシコ等)
・ウロキナーゼのアメリカ市場規模推移
・ウロキナーゼのカナダ市場規模推移
・ウロキナーゼのメキシコ市場規模推移
・ウロキナーゼのヨーロッパ市場分析(ドイツ、イギリス、ロシア、フランス、イタリア等)
・ウロキナーゼのドイツ市場規模推移
・ウロキナーゼのイギリス市場規模推移
・ウロキナーゼのロシア市場規模推移
・ウロキナーゼのアジア市場分析(日本、中国、韓国、インド、東南アジア等)
・ウロキナーゼの日本市場規模推移
・ウロキナーゼの中国市場規模推移
・ウロキナーゼの韓国市場規模推移
・ウロキナーゼのインド市場規模推移
・ウロキナーゼの東南アジア市場規模推移
・ウロキナーゼの南米・中東・アフリカ市場分析
・ウロキナーゼの種類別分析/市場規模推移(ウロキナーゼ粉、ウロキナーゼ溶液)
・ウロキナーゼの用途別分析/市場規模推移(病院、診療所、その他)
・ウロキナーゼの市場予測(地域別予測、種類別予測、用途別予測)
・ウロキナーゼの販売チャネル・代理店・貿易業者・ディーラー分析
【レポートの概要】

Urokinase, also known as urokinase-type plasminogen activator (uPA), is a serine protease present in humans and other animals. The human urokinase protein was discovered, but not named, by McFarlane and Pilling in 1947. Urokinase was originally isolated from human urine, and it is also present in the blood and in the extracellular matrix of many tissues. The primary physiological substrate of this enzyme is plasminogen, which is an inactive form (zymogen) of the serine protease plasmin.

Scope of the Report:
This report focuses on the Urokinase in Global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

Market Segment by Manufacturers, this report covers
NDPharm
Wanhua Biochem
Jiangxi Haoran Bio-Pharma
Jiangsu Aidea Pharmaceutical

Market Segment by Regions, regional analysis covers
North America (USA, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Columbia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
Urokinase Powder
Urokinase Solution

Market Segment by Applications, can be divided into
Hospital
Clinic
Others

There are 15 Chapters to deeply display the global Urokinase market.

Chapter 1, to describe Urokinase Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Urokinase, with sales, revenue, and price of Urokinase, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Urokinase, for each region, from 2012 to 2017;

Chapter 5, 6, 7, 8 and 9, to analyze the key regions, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2012 to 2017;

Chapter 12, Urokinase market forecast, by regions, type and application, with sales and revenue, from 2017 to 2022;

Chapter 13, 14 and 15, to describe Urokinase sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

【レポートの目次】

Table of Contents

1 Market Overview
1.1 Urokinase Introduction
1.2 Market Analysis by Type
1.2.1 Urokinase Powder
1.2.2 Urokinase Solution
1.3 Market Analysis by Applications
1.3.1 Hospital
1.3.2 Clinic
1.3.3 Others
1.4 Market Analysis by Regions
1.4.1 North America (USA, Canada and Mexico)
1.4.1.1 USA Market States and Outlook (2012-2022)
1.4.1.2 Canada Market States and Outlook (2012-2022)
1.4.1.3 Mexico Market States and Outlook (2012-2022)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2012-2022)
1.4.2.2 France Market States and Outlook (2012-2022)
1.4.2.3 UK Market States and Outlook (2012-2022)
1.4.2.4 Russia Market States and Outlook (2012-2022)
1.4.2.5 Italy Market States and Outlook (2012-2022)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2012-2022)
1.4.3.2 Japan Market States and Outlook (2012-2022)
1.4.3.3 Korea Market States and Outlook (2012-2022)
1.4.3.4 India Market States and Outlook (2012-2022)
1.4.3.5 Southeast Asia Market States and Outlook (2012-2022)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2012-2022)
1.4.4.2 Egypt Market States and Outlook (2012-2022)
1.4.4.3 Saudi Arabia Market States and Outlook (2012-2022)
1.4.4.4 South Africa Market States and Outlook (2012-2022)
1.4.4.5 Nigeria Market States and Outlook (2012-2022)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 NDPharm
2.1.1 Business Overview
2.1.2 Urokinase Type and Applications
2.1.2.1 Type 1
2.1.2.2 Type 2
2.1.3 NDPharm Urokinase Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Wanhua Biochem
2.2.1 Business Overview
2.2.2 Urokinase Type and Applications
2.2.2.1 Type 1
2.2.2.2 Type 2
2.2.3 Wanhua Biochem Urokinase Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 Jiangxi Haoran Bio-Pharma
2.3.1 Business Overview
2.3.2 Urokinase Type and Applications
2.3.2.1 Type 1
2.3.2.2 Type 2
2.3.3 Jiangxi Haoran Bio-Pharma Urokinase Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Jiangsu Aidea Pharmaceutical
2.4.1 Business Overview
2.4.2 Urokinase Type and Applications
2.4.2.1 Type 1
2.4.2.2 Type 2
2.4.3 Jiangsu Aidea Pharmaceutical Urokinase Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Urokinase Market Competition, by Manufacturer
3.1 Global Urokinase Sales and Market Share by Manufacturer
3.2 Global Urokinase Revenue and Market Share by Manufacturer
3.3 Market Concentration Rate
3.3.1 Top 3 Urokinase Manufacturer Market Share
3.3.2 Top 6 Urokinase Manufacturer Market Share
3.4 Market Competition Trend
4 Global Urokinase Market Analysis by Regions
4.1 Global Urokinase Sales, Revenue and Market Share by Regions
4.1.1 Global Urokinase Sales by Regions (2012-2017)
4.1.2 Global Urokinase Revenue by Regions (2012-2017)
4.2 North America Urokinase Sales and Growth (2012-2017)
4.3 Europe Urokinase Sales and Growth (2012-2017)
4.4 Asia-Pacific Urokinase Sales and Growth (2012-2017)
4.5 South America Urokinase Sales and Growth (2012-2017)
4.6 Middle East and Africa Urokinase Sales and Growth (2012-2017)
5 North America Urokinase by Countries
5.1 North America Urokinase Sales, Revenue and Market Share by Countries
5.1.1 North America Urokinase Sales by Countries (2012-2017)
5.1.2 North America Urokinase Revenue by Countries (2012-2017)
5.2 USA Urokinase Sales and Growth (2012-2017)
5.3 Canada Urokinase Sales and Growth (2012-2017)
5.4 Mexico Urokinase Sales and Growth (2012-2017)
6 Europe Urokinase by Countries
6.1 Europe Urokinase Sales, Revenue and Market Share by Countries
6.1.1 Europe Urokinase Sales by Countries (2012-2017)
6.1.2 Europe Urokinase Revenue by Countries (2012-2017)
6.2 Germany Urokinase Sales and Growth (2012-2017)
6.3 UK Urokinase Sales and Growth (2012-2017)
6.4 France Urokinase Sales and Growth (2012-2017)
6.5 Russia Urokinase Sales and Growth (2012-2017)
6.6 Italy Urokinase Sales and Growth (2012-2017)
7 Asia-Pacific Urokinase by Countries
7.1 Asia-Pacific Urokinase Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Urokinase Sales by Countries (2012-2017)
7.1.2 Asia-Pacific Urokinase Revenue by Countries (2012-2017)
7.2 China Urokinase Sales and Growth (2012-2017)
7.3 Japan Urokinase Sales and Growth (2012-2017)
7.4 Korea Urokinase Sales and Growth (2012-2017)
7.5 India Urokinase Sales and Growth (2012-2017)
7.6 Southeast Asia Urokinase Sales and Growth (2012-2017)
8 South America Urokinase by Countries
8.1 South America Urokinase Sales, Revenue and Market Share by Countries
8.1.1 South America Urokinase Sales by Countries (2012-2017)
8.1.2 South America Urokinase Revenue by Countries (2012-2017)
8.2 Brazil Urokinase Sales and Growth (2012-2017)
8.3 Argentina Urokinase Sales and Growth (2012-2017)
8.4 Columbia Urokinase Sales and Growth (2012-2017)
9 Middle East and Africa Urokinase by Countries
9.1 Middle East and Africa Urokinase Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Urokinase Sales by Countries (2012-2017)
9.1.2 Middle East and Africa Urokinase Revenue by Countries (2012-2017)
9.2 Saudi Arabia Urokinase Sales and Growth (2012-2017)
9.3 UAE Urokinase Sales and Growth (2012-2017)
9.4 Egypt Urokinase Sales and Growth (2012-2017)
9.5 Nigeria Urokinase Sales and Growth (2012-2017)
9.6 South Africa Urokinase Sales and Growth (2012-2017)
10 Global Urokinase Market Segment by Type
10.1 Global Urokinase Sales, Revenue and Market Share by Type (2012-2017)
10.1.1 Global Urokinase Sales and Market Share by Type (2012-2017)
10.1.2 Global Urokinase Revenue and Market Share by Type (2012-2017)
10.2 Urokinase Powder Sales Growth and Price
10.2.1 Global Urokinase Powder Sales Growth (2012-2017)
10.2.2 Global Urokinase Powder Price (2012-2017)
10.3 Urokinase Solution Sales Growth and Price
10.3.1 Global Urokinase Solution Sales Growth (2012-2017)
10.3.2 Global Urokinase Solution Price (2012-2017)
11 Global Urokinase Market Segment by Application
11.1 Global Urokinase Sales Market Share by Application (2012-2017)
11.2 Hospital Sales Growth (2012-2017)
11.3 Clinic Sales Growth (2012-2017)
11.4 Others Sales Growth (2012-2017)
12 Urokinase Market Forecast (2017-2022)
12.1 Global Urokinase Sales, Revenue and Growth Rate (2017-2022)
12.2 Urokinase Market Forecast by Regions (2017-2022)
12.2.1 North America Urokinase Market Forecast (2017-2022)
12.2.2 Europe Urokinase Market Forecast (2017-2022)
12.2.3 Asia-Pacific Urokinase Market Forecast (2017-2022)
12.2.4 South America Urokinase Market Forecast (2017-2022)
12.2.5 Middle East and Africa Urokinase Market Forecast (2017-2022)
12.3 Urokinase Market Forecast by Type (2017-2022)
12.4 Urokinase Market Forecast by Application (2017-2022)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Analyst Introduction
15.3 Data Source

List of Tables and Figures

Figure Urokinase Picture
Table Product Specifications of Urokinase
Figure Global Sales Market Share of Urokinase by Types in 2016
Table Urokinase Types for Major Manufacturers
Figure Urokinase Powder Picture
Figure Urokinase Solution Picture
Table Urokinase Sales Market Share by Applications in 2016
Figure Hospital Picture
Figure Clinic Picture
Figure Others Picture
Figure USA Urokinase Revenue (Value) and Growth Rate (2012-2022)
Figure Canada Urokinase Revenue (Value) and Growth Rate (2012-2022)
Figure Mexico Urokinase Revenue (Value) and Growth Rate (2012-2022)
Figure Germany Urokinase Revenue (Value) and Growth Rate (2012-2022)
Figure France Urokinase Revenue (Value) and Growth Rate (2012-2022)
Figure UK Urokinase Revenue (Value) and Growth Rate (2012-2022)
Figure Russia Urokinase Revenue (Value) and Growth Rate (2012-2022)
Figure Italy Urokinase Revenue (Value) and Growth Rate (2012-2022)
Figure China Urokinase Revenue (Value) and Growth Rate (2012-2022)
Figure Japan Urokinase Revenue (Value) and Growth Rate (2012-2022)
Figure Korea Urokinase Revenue (Value) and Growth Rate (2012-2022)
Figure India Urokinase Revenue (Value) and Growth Rate (2012-2022)
Figure Southeast Asia Urokinase Revenue (Value) and Growth Rate (2012-2022)
Figure Brazil Urokinase Revenue (Value) and Growth Rate (2012-2022)
Figure Egypt Urokinase Revenue (Value) and Growth Rate (2012-2022)
Figure Saudi Arabia Urokinase Revenue (Value) and Growth Rate (2012-2022)
Figure South Africa Urokinase Revenue (Value) and Growth Rate (2012-2022)
Figure Nigeria Urokinase Revenue (Value) and Growth Rate (2012-2022)
Table NDPharm Basic Information, Manufacturing Base and Competitors
Table NDPharm Urokinase Type and Applications
Table NDPharm Urokinase Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Wanhua Biochem Basic Information, Manufacturing Base and Competitors
Table Wanhua Biochem Urokinase Type and Applications
Table Wanhua Biochem Urokinase Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Jiangxi Haoran Bio-Pharma Basic Information, Manufacturing Base and Competitors
Table Jiangxi Haoran Bio-Pharma Urokinase Type and Applications
Table Jiangxi Haoran Bio-Pharma Urokinase Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Jiangsu Aidea Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table Jiangsu Aidea Pharmaceutical Urokinase Type and Applications
Table Jiangsu Aidea Pharmaceutical Urokinase Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
Table Global Urokinase Sales by Manufacturer (2016-2017)
Figure Global Urokinase Sales Market Share by Manufacturer in 2016
Figure Global Urokinase Sales Market Share by Manufacturer in 2017
Table Global Urokinase Revenue by Manufacturer (2016-2017)
Figure Global Urokinase Revenue Market Share by Manufacturer in 2016
Figure Global Urokinase Revenue Market Share by Manufacturer in 2017
Figure Global Urokinase Sales and Growth (2012-2017)
Figure Global Urokinase Revenue and Growth (2012-2017)
Table Global Urokinase Sales by Regions (2012-2017)
Table Global Urokinase Sales Market Share by Regions (2012-2017)
Table Global Urokinase Revenue by Regions (2012-2017)
Table Global Urokinase Revenue Market Share by Regions in 2012
Table Global Urokinase Revenue Market Share by Regions in 2016
Figure North America Urokinase Sales and Growth (2012-2017)
Figure Europe Urokinase Sales and Growth (2012-2017)
Figure Asia-Pacific Urokinase Sales and Growth (2012-2017)
Figure South America Urokinase Sales and Growth (2012-2017)
Figure Middle East and Africa Urokinase Sales and Growth (2012-2017)
Figure North America Urokinase Revenue and Growth (2012-2017)
Table North America Urokinase Sales by Countries (2012-2017)
Table North America Urokinase Sales Market Share by Countries (2012-2017)
Figure North America Urokinase Sales Market Share by Countries in 2012
Figure North America Urokinase Sales Market Share by Countries in 2016
Table North America Urokinase Revenue by Countries (2012-2017)
Table North America Urokinase Revenue Market Share by Countries (2012-2017)
Figure North America Urokinase Revenue Market Share by Countries in 2012
Figure North America Urokinase Revenue Market Share by Countries in 2016
Figure USA Urokinase Sales and Growth (2012-2017)
Figure Canada Urokinase Sales and Growth (2012-2017)
Figure Mexico Urokinase Sales and Growth (2012-2017)
Figure Europe Urokinase Revenue and Growth (2012-2017)
Table Europe Urokinase Sales by Countries (2012-2017)
Table Europe Urokinase Sales Market Share by Countries (2012-2017)
Table Europe Urokinase Revenue by Countries (2012-2017)
Table Europe Urokinase Revenue Market Share by Countries in 2012
Table Europe Urokinase Revenue Market Share by Countries in 2016
Figure Germany Urokinase Sales and Growth (2012-2017)
Figure UK Urokinase Sales and Growth (2012-2017)
Figure France Urokinase Sales and Growth (2012-2017)
Figure Russia Urokinase Sales and Growth (2012-2017)
Figure Italy Urokinase Sales and Growth (2012-2017)
Figure Asia-Pacific Urokinase Revenue and Growth (2012-2017)
Table Asia-Pacific Urokinase Sales by Countries (2012-2017)
Table Asia-Pacific Urokinase Sales Market Share by Countries (2012-2017)
Table Asia-Pacific Urokinase Sales Market Share by Countries (2012-2017)
Table Asia-Pacific Urokinase Revenue by Countries (2012-2017)
Table Asia-Pacific Urokinase Revenue Market Share by Countries (2012-2017)
Figure China Urokinase Sales and Growth (2012-2017)
Figure Japan Urokinase Sales and Growth (2012-2017)
Figure Korea Urokinase Sales and Growth (2012-2017)
Figure India Urokinase Sales and Growth (2012-2017)
Figure Southeast Asia Urokinase Sales and Growth (2012-2017)
Figure South America Urokinase Revenue and Growth (2012-2017)
Table South America Urokinase Sales by Countries (2012-2017)
Table South America Urokinase Sales Market Share by Countries (2012-2017)
Figure South America Urokinase Sales Market Share by Countries in 2016
Table South America Urokinase Revenue by Countries (2012-2017)
Table South America Urokinase Revenue Market Share by Countries (2012-2017)
Figure South America Urokinase Revenue Market Share by Countries in 2012
Figure South America Urokinase Revenue Market Share by Countries in 2016
Figure Brazil Urokinase Sales and Growth (2012-2017)
Figure Argentina Urokinase Sales and Growth (2012-2017)
Figure Columbia Urokinase Sales and Growth (2012-2017)
Figure Middle East and Africa Urokinase Revenue and Growth (2012-2017)
Table Middle East and Africa Urokinase Sales by Countries (2012-2017)
Table Middle East and Africa Urokinase Sales Market Share by Countries (2012-2017)
Figure Middle East and Africa Urokinase Sales Market Share by Countries in 2016
Table Middle East and Africa Urokinase Revenue by Countries (2012-2017)
Table Middle East and Africa Urokinase Revenue Market Share by Countries (2012-2017)
Figure Middle East and Africa Urokinase Revenue Market Share by Countries in 2012
Figure Middle East and Africa Urokinase Revenue Market Share by Countries in 2016
Figure Saudi Arabia Urokinase Sales and Growth (2012-2017)
Figure UAE Urokinase Sales and Growth (2012-2017)
Figure Egypt Urokinase Sales and Growth (2012-2017)
Figure Nigeria Urokinase Sales and Growth (2012-2017)
Figure South Africa Urokinase Sales and Growth (2012-2017)
Table Global Urokinase Sales by Type (2012-2017)
Table Global Urokinase Sales Share by Type (2012-2017)
Table Global Urokinase Revenue by Type (2012-2017)
Table Global Urokinase Revenue Share by Type (2012-2017)
Figure Global Urokinase Powder Sales Growth (2012-2017)
Figure Global Urokinase Powder Price (2012-2017)
Figure Global Urokinase Solution Sales Growth (2012-2017)
Figure Global Urokinase Solution Price (2012-2017)
Table Global Urokinase Sales by Application (2012-2017)
Table Global Urokinase Sales Share by Application (2012-2017)
Figure Global Hospital Sales Growth (2012-2017)
Figure Global Clinic Sales Growth (2012-2017)
Figure Global Others Sales Growth (2012-2017)
Figure Global Urokinase Sales, Revenue and Growth Rate (2017 -2022)
Table Global Urokinase Sales Forecast by Regions (2017-2022)
Table Global Urokinase Market Share Forecast by Regions (2017-2022)
Figure North America Sales Urokinase Market Forecast (2017-2022)
Figure Europe Sales Urokinase Market Forecast (2017-2022)
Figure Asia-Pacific Sales Urokinase Market Forecast (2017-2022)
Figure South America Sales Urokinase Market Forecast (2017-2022)
Figure Middle East and Africa Sales Urokinase Market Forecast (2017-2022)
Table Global Urokinase Sales Forecast by Type (2017-2022)
Table Global Urokinase Market Share Forecast by Type (2017-2022)
Table Global Urokinase Sales Forecast by Application (2017-2022)
Table Global Urokinase Market Share Forecast by Application (2017-2022)
Table Distributors/Traders/ Dealers List

【レポートのキーワード】

ウロキナーゼ、ウロキナーゼ粉、ウロキナーゼ溶液、病院、診療所

★調査レポート[ウロキナーゼの世界市場:メーカー別、地域別、種類別、用途別、市場予測(~2022)] (コード:GIR8012227)販売に関する免責事項を必ずご確認ください。
★調査レポート[ウロキナーゼの世界市場:メーカー別、地域別、種類別、用途別、市場予測(~2022)]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆